Alexion Pharmaceuticals
Michele Gianatti, PhD, currently serves as the Associate Director of Global Scientific Communications in Neurology at Alexion Pharmaceuticals, Inc. since February 2025. Prior to this role, Michele was a Medical Advisor in Acute Care at AstraZeneca and held the position of Medical Science Liaison (MSL) for Neuro at Alexion Pharmaceuticals from May 2022 to February 2025. Michele’s academic background includes a PhD in Neuroscience from the University of Oslo, where significant research and presentations were conducted at national and international scientific conferences. Additional experience encompasses roles as a Staff Engineer and Research Assistant at the Kavli Institute for Systems Neuroscience, and as an Account Executive at Synergy Vision, focusing on key opinion leader engagement and medical material management within the pharmaceutical sector. Educational qualifications include a Master's degree in International MSc in Neuroscience from the Norwegian University of Science and Technology and a Bachelor's in Psychology from Università Cattolica del Sacro Cuore.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.